Immediate Impact
61 standout
Citing Papers
A covalent peptide-based lysosome-targeting protein degradation platform for cancer immunotherapy
2025 Standout
Therapy-induced senescent cancer cells contribute to cancer progression by promoting ribophorin 1-dependent PD-L1 upregulation
2025 Standout
Works of Dodderi S. Samiulla being referenced
PD-1 derived CA-170 is an oral immune checkpoint inhibitor that exhibits preclinical anti-tumor efficacy
2021
A Rationally Designed Peptide Antagonist of the PD-1 Signaling Pathway as an Immunomodulatory Agent for Cancer Therapy
2019
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Dodderi S. Samiulla | 180 | 79 | 70 | 105 | 16 | 373 | |
| Hsia‐Fen Hsu | 82 | 40 | 157 | 51 | 21 | 458 | |
| Jitender Monga | 57 | 47 | 142 | 49 | 26 | 377 | |
| Hina Amin | 91 | 62 | 248 | 33 | 19 | 426 | |
| Hala E. Abdel‐Hamied | 61 | 87 | 156 | 91 | 15 | 428 | |
| Shahrzad Zamani Taghizadeh Rabe | 59 | 45 | 118 | 69 | 20 | 357 | |
| Chung Yeng Looi | 62 | 30 | 184 | 61 | 14 | 406 | |
| Haiding Huang | 52 | 41 | 167 | 96 | 16 | 402 | |
| Juni Chakraborty | 106 | 32 | 253 | 93 | 9 | 455 | |
| Yiyi Ye | 84 | 24 | 199 | 44 | 17 | 381 | |
| Elbert L. Myles | 41 | 34 | 135 | 62 | 17 | 405 |
All Works
Loading papers...